AAAAAA
Results: 1-25/37
Authors:
Cataland, SR
Daugherty, CK
Weseman, EC
Larson, RA
Citation: Sr. Cataland et al., Preliminary experience with a new chemotherapy regimen for adults with acute lymphoblastic leukemia, LEUK LYMPH, 41(3-4), 2001, pp. 297-307
Authors:
Kantarjian, HM
Hoelzer, D
Larson, RA
Citation: Hm. Kantarjian et al., Advances in the treatment of adult acute lymphocytic leukemia, part II - Preface, HEMAT ONCOL, 15(1), 2001, pp. XI-XI
Authors:
Lai, F
Godley, LA
Joslin, J
Fernald, AA
Liu, J
Espinosa, R
Zhao, ND
Pamintuan, L
Till, BG
Larson, RA
Qian, ZJ
Le Beau, MM
Citation: F. Lai et al., Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q), GENOMICS, 71(2), 2001, pp. 235-245
Authors:
Larson, RA
Citation: Ra. Larson, New agents for induction and postremission therapy of acute myeloid leukemia, LEUKEMIA, 15(4), 2001, pp. 675-676
Authors:
Velazquez, OC
Larson, RA
Baum, RA
Carpenter, JP
Golden, MA
Mitchell, ME
Pyeron, A
Barker, CF
Fairman, RM
Citation: Oc. Velazquez et al., Gender-related differences in infrarenal aortic aneurysm morphologic features: Issues relevant to Ancure and Talent endografts, J VASC SURG, 33(2), 2001, pp. S77-S84
Authors:
Mrozek, K
Prior, TW
Edwards, C
Marcucci, G
Carroll, AJ
Snyder, PJ
Koduru, PRK
Theil, KS
Pettenati, MJ
Archer, KJ
Caligiuri, MA
Vardiman, JW
Kolitz, JE
Larson, RA
Bloomfield, CD
Citation: K. Mrozek et al., Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B study, J CL ONCOL, 19(9), 2001, pp. 2482-2492
Authors:
Morrison, VA
Rai, KR
Peterson, BL
Kolitz, JE
Elias, L
Appelbaum, FR
Hines, JD
Shepherd, L
Martell, RE
Larson, RA
Schiffer, CA
Citation: Va. Morrison et al., Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011, J CL ONCOL, 19(16), 2001, pp. 3611-3621
Authors:
Sievers, EL
Larson, RA
Stadtmauer, EA
Estey, E
Lowenberg, B
Dombret, H
Karanes, C
Theobald, M
Bennett, JM
Sherman, ML
Berger, MS
Eten, CB
Loken, MR
van Dongen, JJM
Bernstein, ID
Appelbaum, FR
Citation: El. Sievers et al., Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse, J CL ONCOL, 19(13), 2001, pp. 3244-3254
Authors:
Siston, AK
List, MA
Daugherty, CK
Banik, DM
Menke, C
Cornetta, K
Larson, RA
Citation: Ak. Siston et al., Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation, BONE MAR TR, 27(11), 2001, pp. 1181-1188
Authors:
Larson, RA
Citation: Ra. Larson, Current use and future development of gemtuzumab ozogamicin, SEM HEMATOL, 38(3), 2001, pp. 24-31
Adenoviral mediated uteroglobin gene transfer to the adventitia reduces arterial intimal hyperplasia
Authors:
Lombardi, JV
Naji, M
Larson, RA
Ryan, SV
Naji, A
Koeberlein, B
Golden, MA
Citation: Jv. Lombardi et al., Adenoviral mediated uteroglobin gene transfer to the adventitia reduces arterial intimal hyperplasia, J SURG RES, 99(2), 2001, pp. 377-380
Authors:
Cervini-Silva, J
Larson, RA
Wu, J
Stucki, JW
Citation: J. Cervini-silva et al., Transformation of chlorinated aliphatic compounds by ferruginous smectite, ENV SCI TEC, 35(4), 2001, pp. 805-809
Authors:
Whitman, SP
Archer, KJ
Feng, L
Baldus, C
Becknell, B
Carlson, BD
Carroll, AJ
Mrozek, K
Vardiman, JW
George, SL
Kolitz, JE
Larson, RA
Bloomfield, CD
Caligiuri, NA
Citation: Sp. Whitman et al., Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study, CANCER RES, 61(19), 2001, pp. 7233-7239
Authors:
Baer, MR
Stewart, GC
Dodge, RK
Leget, G
Sule, N
Mrozek, K
Schiffer, CA
Powel, BL
Kolitz, JE
Moore, JO
Stone, RM
Davey, FR
Carrol, AJ
Larson, RA
Bloomfield, CD
Citation: Mr. Baer et al., High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361), BLOOD, 97(11), 2001, pp. 3574-3580
Results of recent clinical trials in acute lymphoblastic leukemia by the cancer and leukemia group B
Authors:
Larson, RA
Dodge, RK
Szatrowski, TP
Frankel, SR
Citation: Ra. Larson et al., Results of recent clinical trials in acute lymphoblastic leukemia by the cancer and leukemia group B, HEMAT BLOOD, 40, 2001, pp. 393-401
Authors:
Byrd, JC
Carroll, AJ
Caligiuri, MA
Larson, RA
Bloomfield, CD
Citation: Jc. Byrd et al., Recent genetic studies of adult patients with acute myeloid leukemia performed by the Cancer and Leukemia Group B, HEMAT BLOOD, 40, 2001, pp. 449-456
Authors:
Larson, RA
Citation: Ra. Larson, Myeloid leukemia after cytotoxic therapy and other hematotoxins, J TOX E H A, 61(5-6), 2000, pp. 381-386
Authors:
Larson, RA
Citation: Ra. Larson, Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B, HEMAT ONCOL, 14(6), 2000, pp. 1367
Authors:
Kantarjian, HM
Hoelzer, D
Larson, RA
Citation: Hm. Kantarjian et al., Advances in the treatment of adult acute lymphocytic leukemia, part I - Preface, HEMAT ONCOL, 14(6), 2000, pp. XIII-XIII
Authors:
Wang, PW
Eisenbart, JD
Espinosa, R
Davis, EM
Larson, RA
Le Beau, MM
Citation: Pw. Wang et al., Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map, GENOMICS, 67(1), 2000, pp. 28-39
Authors:
Larson, RA
Naji, M
Lombardi, JV
Naji, A
Koeberlein, B
Golden, MA
Citation: Ra. Larson et al., Adenoviral-mediated uteroglobin gene transfer inhibits neointimal hyperplasia after balloon injury in the rat carotid artery, J VASC SURG, 32(6), 2000, pp. 1111-1116
Authors:
Pappas, PJ
Larson, RA
Sidawy, AN
Citation: Pj. Pappas et al., Adenoviral-mediated uteroglobin gene transfer inhibits neointimal hyperplasia after balloon injury in the rat carotid artery - Discussion, J VASC SURG, 32(6), 2000, pp. 1116-1117
Authors:
Hensley, ML
Peterson, B
Silver, RT
Larson, RA
Schiffer, CA
Szatrowski, TP
Citation: Ml. Hensley et al., Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: Analysis of cancer and leukemia Group B 9013, J CL ONCOL, 18(6), 2000, pp. 1301-1308
Authors:
Larson, RA
Cervini-Silva, J
Citation: Ra. Larson et J. Cervini-silva, Dechlorination of substituted trichloromethanes by an iron(II) porphyrin, ENV TOX CH, 19(3), 2000, pp. 543-548
Authors:
Sobecks, RM
Daugherty, CK
Hallahan, DE
Laport, GF
Wagner, ND
Larson, RA
Citation: Rm. Sobecks et al., A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment ofadvanced hematologic malignancies, BONE MAR TR, 25(8), 2000, pp. 807-813